Tumour lysis syndrome
Also known as: Tumor-lysis syndrome / Tumor Lysis Syndrome / Tumor lysis syndrome (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00049 | Rasburicase | A recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00049 | Rasburicase | Uric acid | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB04854 | Febuxostat | 1 / 2 | Terminated | 1 |
| DB00049 | Rasburicase | 1 / 2 | Completed | 1 |
| DB00049 | Rasburicase | 2 | Completed | 1 |
| DB00437 | Allopurinol | 3 | Completed | 2 |
| DB04854 | Febuxostat | 3 | Completed | 1 |
| DB00049 | Rasburicase | 3 | Completed | 1 |
| DB05321 | PEG-uricase | 4 | Active Not Recruiting | 1 |
| DB09208 | Pegloticase | 4 | Active Not Recruiting | 1 |
| DB00049 | Rasburicase | 4 | Active Not Recruiting | 1 |
| DB00049 | Rasburicase | 4 | Completed | 2 |
| DB08844 | Uric acid | 4 | Active Not Recruiting | 1 |
| DB00049 | Rasburicase | Not Available | Completed | 1 |